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Although female sterility wasinducedinexperimental animalsby active immuni-
zation with sperm (1, 2), and antibodies that react with human sperm were found
to be present in sera ofinfertile women (3), no strong correlation has been found
between the presence ofsuch antibodies and naturally occurringhuman female in-
fertility (4, 5). However, Iscjima et al. (6) reported the novel finding that sera of
infertile women inactivate human sperm motilityinthe presence ofguinea pigcom-
plement. Approximately 17% ofinfertilewomenwith unknowncausehad antibodies
in their sera thatinactivated human sperm motility inthe presence ofcomplement.
No such antibody was detectable in sera of parous women. These findings led to
agenerally acceptedhypothesis thatthe presence ofsuch antibodies in sera ofinfer-
tilewomen can beregarded asthe causeoffemal infertility (7). Thus, the specificities
and immunobiological properties of antibodies present in sera of infertile women
showing complement-dependent inactivation of sperm motility are of crucial im-
portanceforunderstandingthebiological mechanismoffemale infertility. However,
the activity of such antibodies in sera of infertile women is generally lower than a
sperm immobilization titer of 1:200 (200 SI5o) (8), and certain serum components
ofnormal subjects showed nonspecific binding with human sperm. Therefore, im-
munobiological studies on infertility have been difficult to performin furtherdetail.
To overcome this difficulty, ahumanmAb H6-3C4, inducingcomplement-dependent
sperm immotility, was established after fusion oflymphocytes from an infertile pa-
tient (patient MI), showing high-titer antisperm antibodies, with mouse myeloma
NSl (9). The antibody is an IgM withXlight chain, and reacts with ejaculated sperm,
but not withtesticular sperm. The antibody showed astrong inactivation ofhuman
sperm motility in the presence of complement. The binding ofH6-3C4 antibody
to sperm was inhibited by the serum antibodies ofpatient MI; thus the serum anti-
bodies ofMI and antibody H6-3C4 must be directed to the same epitope structure
present at the surface of ejaculated human sperm (9). It is essential, therefore, to
elucidate the chemical properties ofantigen defined by mAb H6-3C4. This paper
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describes the carbohydrate epitope structure defined by this mAb, as well as the chem-
ical properties of carbohydrate antigens expressed at the surface of human sperm.
Materials and Methods
MonoclonalAntibodies.
￿
The mAb H6-3C4 (9) was prepared from hybridoma supernatant
after precipitation with 50% saturated ammonium sulfate, followed by gel filtrationthrough
Sephacryl 5300. Other mAbs used in this study were: (a) IgM antibody 1139 defining
NeuAca2-6Galß1-4GlcNAc (10); (b) IgM antibody M2590 defining NeuAca2-3-
Galßl-4Glc (or -GlcNAc) (11); (c) IgM antibody 1B2 defining Galß1-4G1cNAc (12); (d) IgM
antibody NUH2 defining binary NeuAca2-3Gal0l-4G1cNÁc (IV6NeuAca2-3Galß1-4
G1cNAcVi3NeuAcnLc6; sialyl-I) (Nudeluran, E., U Mandel, H. Clausen, and S. Hakomori,
unpublished data); (e) IgM antibody C6 defining binary Galpl-4G1cNAc
(IV6Gal0l-4G1cNAcnLc6; 1) (13); (f) anti-SSEA-3 defining extended globo structure
Galßl-3Ga1NAcß1-3Gala1-4-Galßl-4Glc (14); and (g) anti-SSEA-4 defining sialyl galac-
tosylgloboside (NeuAca2-3Galß1-3Ga1NAcß1-3Galal-4Galß1-4Glc) (15). These anti-
bodies were prepared, or their epitope structures were established, in this laboratory (The
Biomembrane Institute). Two anti-i antisera, Bostrum and Dench, were provided by Mrs.
Osaki of Puget Sound Blood Bank, Seattle, WA.
Sperm Preparation.
￿
For determination ofantibody binding or mobility ofsperm, asufficient
quantity of freshly ejaculated semen was diluted with PBS, and sperm cells were collected
on centrifugation (3,000 rpm), washed with PBS containing 1% FCSy and suspended (106/ml)
for the assays. For extraction of glycolipid antigens, pooled ejaculated semen was collected
and frozen until a sufficiently large quantity was accumulated. -700 ml of semen was cen-
trifuged at 3,000 rpm at room temperature for 20 min, and the sperm pellet was suspended
in the same volume of PBS and centrifuged again. The sperm pellet, weighing 6.2 g, was
extracted with 150 ml of isopropanol/hexane/water (55:20:25 vol/vol/vol) (see below).
GlycolipidPreparation.
￿
The following glycolipids were prepared from the upper neutral or
ganglioside fraction ofhuman blood group O erythrocytes (16), human placenta (17), orhuman
sperm (this paper): 2-"3 sialyl paragloboside (IV'NeuAcnLc4) (18); 2-6 sialyl paraglobo-
side (IV'NeuAcnLc4); 2-3 sialyl lactonorhexaosylceramide (VI'NeuAcnLc6) (16); 2-6 sialyl
lactonorhexaosylceramide (VI6NeuAcnLc6) (16); lactonoroctaosylceramide and sialyllac-
tonoroctaosylceramide (VIII'NeuAcnLcs) (19); LeX nonasaccharide (VII'FucnLcs; Z,
glycolipid) (20); lactoisooctaosylceramide (IV6Galß1-"4-GlcNÁcnLc6, C6 antigen or I-anti-
gen) (21, 22); 2-3 disialyl lactoisooctaosylceramide (VI3NeuAcIV6NeuAc2-3Galül-4Glc-
NAcnLc6; disialyl I-antigen) (22, 23); and GM3 ganglioside. Structures of these glycolipids
are shown in Table I. The method ofpreparation was described previously (24). Briefly, tissues
were extracted by isopropanol/hexane/water 55 :30:25, followed by Folch's partition repeated
three times, DEAE cellulose chromatography, HPLC on porous silica gel column (Iatrobeads
6RS8010), and finally, purification on high-performance thin-layer chromatography (HPTLC)'
as free state or as acetate. Each glycolipid preparation was homogeneous on HPTLC, and
some oftheir structures were identified by nuclear magnetic resonance (NMR) and fast-atom
bombardment mass spectrometry (FAB-MS).
Immunostaining andSolid-Phase RIAfor Glycolipids.
￿
TLC immunostaining of glycolipids was
performed on HPTLC (Baker Chemical Co., Phillipsburg, NJ; or Whatman Co., Kent, En-
gland), according to a modified method (14, 20) of a procedure originally described by Mag-
nani et al. (25). Briefly, the HPTLC plate, after development, was treated with 3% BSA in
PBS, followed by reaction with the primary antibody at 4°C overnight. Subsequently, the
plate was treated with the secondary antibody at room temperature for 1 h, and 1251-pro-
tein A for 0.5 h, then washed three times with PBS, dried, and subjected to autoradiography.
Solid-phase RIA of various glycolipids was performed on 96-well flexible vinyl plastic plate
(Falcon 3000, Becton Dickinson & Co., Oxnard, CA) as previously described (26).
' Abbreviations used in thispaper . FAB-MS, fast-atom bombardment mass spectrometry; HPTLC, high-
performance thin-layer chromatography; NMR, nuclear magnetic resonance.W a
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Determination ofAntibody Binding on Sperm Cells by ELISA Assay or RIA.
￿
A suspension of
sperm cells in PBS containing 2 x 106/ml was prepared. 50-w1 aliquots of sperm cell sus-
pension were placed in each well of a flexible microplate (Falcon 3004, Becton Dickinson
& Co.) and the plate was placed on a heating stage and dried at 45°C for 30 min. Each well
of the microplate then had 3 % BSA in PBS added and was incubated for 1 h, followed by
incubation with undiluted supernatant ofhybridoma or 300 times diluted anti-i serum (Dench
or Bostrum) with PBS containing 0.1% BSA as the primary antibody for 1 h. For ELISA,
eachwell was treatedwith 1,000 times diluted peroxidase-conjugated anti-mouse oranti-human
gamma globulin, followed by reaction with O-phenylenediamine-hydrogen peroxide to de-
velop color, and if necessary, the intensity of the color was measured by ELISA colorimeter
fitted for 96-well plate. For RIA, the secondary antibody was added instead of peroxidase-
conjugated antibody, washed, subsequently combined with 1251-labeled protein A, and
counted by gamma counter after excision of each well.
Complement-dependent Immobilization Test.
￿
A complement-dependent sperm immobilization
test was performed as originally described by Isojima et al. (7) with minimal modification.
Briefly, 50 gl of hybridoma supernatant or anti-i serum adequately diluted with PBS con-
taining 1 % heat-inactivated FCS was placed in each well ofa 96-well Falcon 3040 microtissue
culture plate, to which 50 pl of 106/ml live sperm suspended in PBS containing I% FCS was
added, and, subsequently, 10 ul 6f guinea pig serum was added. After 1 h of incubation at
room temperature, live sperm showing active motility were counted. To evaluate sperm im-
mobilization value ofthe antibody, motility ratesof the sperm in the experimental wells were
compared with those of sperm in control wells to which 10 gl of heat-inactivated guinea pig
serum was added. The sperm immobilization value of the antibody was calculated as C/T,
where C and Twere the motility ratesofsperm in the control and experimental wells, respec-
tively. A C/T value >50 was considered positive.
The complement used was from guinea pig serum purchased from ICN Pharmaceuticals
Inc., Irvine, CA (vendor code no. 642831). This complement did not show a cytotoxic effect
on fresh human sperm; however, it did show a cytotoxic effect on sialidase-treated sperm.
Therefore, the test was performed with complement absorbed on sialidase-treated sperm.
The pooled sperm were mixed with 0.5 U/ml sialidase (Clostridiumperfringens sialidase, type
X; Sigma Chemical Co., St. Louis, MO; see below), centrifuged, and washed three times
with PBS. One part of sialidase-treated sperm was mixed with one part of complement, fol-
lowed by centrifugation. The supernatant was treated twice with one part sperm. Such com-
plement showed full activity, but had no cytotoxic effect on sialidase-treated sperm.
Hemagglutination Assay.
￿
Blood group O erythrocytes from umbilical cord and adult pe-
ripheral blood were used for study ofhemagglutination by various antibodies. A suspension
of erythrocytes with an approximate concentration of 0.2% in PBS containing 0.1% BSA
was prepared; 25-wl aliquots were mixed well with 25 ul of serially diluted antibody in each
well ofa 96-well U-bottomed plate, and allowed to stand for2 h at room temperature and at 4°C .
Glycosidase Treatment ofSperm Cells.
￿
Sperm cells fixed on plastic plates, as previously de-
scribed, were treated with Clostridium perfringens sialidase,jackbean S-galactosidase (27) (Sigma
type X, Sigma Chemical Co.), or by both enzymes. Aliquots of 25 ul ofsialidase (0.1 U/ml)
in 20 mM acetate buffer, pH 5.5, were added to each well and incubated for 16 h at 37°C.
To observe the effect of sialidase on the sperm immobilization test, a suspension of 4 x 10'
sperm in 0.5 ml ofPBS containing 1 % heat-inactivated FCS was mixed with 1 U/ml of C. per-
fringens sialidase and incubated for 1 h at 37 °C. Sperm motility was unchanged after this
treatment, compared with the same treatment without sialidase. Endo-R-galactosidaseofEsch-
erichiafreundii, which preferentially cleaves unbranched type 2 chain or its sialylatedderiva-
tives (28), was donated by Dr. Minoru Fukuda (LaJolla Cancer Research Foundation, La
Jolla, CA). The enzyme solution containing 0.1 U/ml in 100 mM acetate buffer, pH 5.0,
was prepared and 50 ul was added to fixed sperm on plastic wells after sialidase treatment
as described above.
Immunofluorescence Assay ofFresh Sperm Cells.
￿
Fresh sperm were mixed with culture super-
natant ofhybridoma, or with PBS containing 100 times diluted anti-i antiserum (eitherDench
or Bostrum). These sperm suspensions, mixed with antibody, were allowed to stand for 30
min at 4°C, centrifuged, and washed once with PBS. The sperm were then treated with FITC-TSUJI ET AL.
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labeled anti-mouse or anti-human Ig, incubated for 30 min at 4°C, washed with PBS, cen-
trifuged, suspended in PBS, and observed by immunofluorescence microscopy.
Results
Reactivity andSpecificity ofmAb H6-3C4 with GlycolipidAntigens by TLC Immunostaining
and by Solid-Phase RIA. Several glycolipids characterized as lacto-series type 2 chain,
separated on HPTLC from erythrocytes and placenta, were immunostained with
H6-3C4 antibody (Fig. 1, A and B). Of the major positive bands identified, lacto-
norhexaosylceramide (nLc6) and lactonoroctaosylceramide (nLcs) were characterized
as neutral glycolipids, and 2-3sialyl norhexaosylceramide (V13NeuAcnLcs), 2-6-
sialyl norhexaosylceramide (VI6NeuAcnLc6), 2-3sialyl noroctaosylceramide
(VIII'NeuAcnLc8), and 2-6sialyl noroctaosylceramide (VIII6NeuAcnLcs) as gan-
gliosides. In addition, Le" nonaosylceramide (Zi glycolipid; VII'FucnLcs) was found
to be reactive. The antibody did not react with lactoisooctaosylceramide (IV6Gal-
01-4GlcNAcnLc6; I antigen) defined by C6 antibody (13), its disialyl derivative
(V13NeuAcIV6NeuAc2-3GaID1-4G1cNAcnLc6), 2-3sialyl paragloboside (IV3Neu-
AcnLc4), 2-6sialyl paragloboside (IV6NeuAcnLc4), or GM3 ganglioside. The re-
activity demonstrated on TLC immunostaining was reproduced on solid-phase RIA,
as shownin Fig. 2. Thus, H6-3C4 reacted with glycolipids having a long unbranched
type 2 chain, regardlessof substitution at the terminal region, but did not react with
those having a branched or shorter type 2 chain. This specificity is similar to that
of anti-i antibodies. However, anti-i antibody Bostrum showed a much more restricted
reactivity with sialylated or fucosylated i-structures (Fig. 1 C, lanes 5-11 and 14).
Symbolized structures ofthese antigens, and their reactivities with H6-3C4 in com-
parison with other antibodies, are summarized in Table II.
The Presence ofLactosaminolipids (Lacto-Series Type 2 Chain Glycolipids) in Human Sperm
Cells. In both Folch's lower and upper phase of sperm cell extracts, we found a se-
ries of glycolipids reacting with 1B2 antibody, which defines Gale1-4G1cNAc struc-
tures, i.e., lactosaminolipids (Fig. 3 B). These glycolipids were identified as nLc4,
nLc6, nLcs, iso-Lnca (IV6Ga1D1-4G1cNAcnLcs), and other higher analogues ofun-
branched and branched unsubstituted lactosaminolipids (Fig. 3 B, lanes 6 and 7).
The Folch's upper phase ofspermalso contained 2-3sialyllactonorhexaosylceramide
(VI3NeuAcnLc6), defined by H6-3C4 antibody as a major compound (Fig. 3 C,
lane 10), and sialyl-I, defined by antibody NUH2 (Fig. 3 D, lane 13).
Comparative Hemagglutination with H6-3C4 and Anti-i Antibodies.
￿
Since the reac-
tivity pattern of various glycolipids with H6-3C4 resembled that seen with anti-i
antibody, which was previously established as an autohemolytic antibody associated
with some hemolytic diseases and myeloma (for review see references 29, 30), we
compared hemagglutination of these two antibodies with umbilical cord blood and
adult erythrocytes. We used a typical anti-i antibody, Dench, which is characterized
by its strong reactivity with neonatal erythrocytes at low temperature (4°C). Anti-
body H6-3C4 also showed stronger hemagglutination with neonatal erythrocytes
at 4°C, as compared with adult erythrocytes or higher temperatures. However, H6-3C4
had a much lowerhemagglutinating power than Dench antibody, as shown in Table III.
Comparative Inhibition of Complement-dependent Sperm Motility by Various mAbs.
￿
Be-
sides the antibody H6-3C4, which reacts with both i and sialyl-i antigens, several
mAbs defining various related structures are available. Therefore, we compared the348
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FIGURE 2. Antibody binding activity of various neolactoseries
glycolipids with H6-3C4 antibody by solid-phaseRIA.(")2-+6 sialyl-
norhexaosylceramide; (O)2-3sialylnorhexaosylceramide; (O)norhex-
aosylcerunide; (/)2-+6 sialylparagloboside; (0)paragloboside; (A)
613 ganglioside (VI3NeuAcV3FucIII3FucnLc6); (A) 2-+3 sialyl-
paragloboside.
reactivity of these antibodies on complement-dependent sperm immotility, using
intact and sialidase-treated sperm. Besides H6-3C4, only the antibody NUH2, which
defines disialyl I structure, inhibited the motility of intact sperm in the presence
of complement. However, when sialidase-treated sperm (which still showed active
motility; see Materials and Methods) were used, antibodies Dench, 1132, and C6
also showed inhibition of the motility (Table IV). It is clear that the receptors in
intact sperm that are susceptible to complement-dependent immobilization consist
of sialyl-i (as defined by H6-3C4) and sialyl-I (as defined by NUH2), whereas those
in sialidase-treated sperm may consist of any type 2 chain terminal structure, as
defined by H6-3C4, Dench, 1132, or C6 (see Discussion).
Reactivity ofSperm Cells with Various mAbs.
￿
The fixed sperm showed a clear reac-
tivity with H6-3C4, anti-i (Dench, anti-N-acetyllactosamine (1132), and anti-I (C6),
as shown in Fig. 4. No reactivity was detected with 1139, which defines 2-6sialyl
paragloboside (IV6NeuAcnLc4). Neither anti-SSEA-3 nor anti-SSEA-4 antibodies
reacted with sperm (data not shown). The sperm cell reactivity with H6-3C4 was
unchanged, whereas that with NUH2 was abolished, after sialidase treatment. In
contrast, the reactivity with anti-i (Dench), anti-N-acetyllactosamine (1132), and anti-I
(C6) was enhanced after sialidase treatment, as shown in Fig. 4.
A weak reactivity, detected by either immunofluorescence or antibody binding
with Dench, C6, and 1132 as applied on sialidase untreated cells fixed on plastic sur-
face, was observed. Such a weak reactivity should be ascribed to spontaneous hy-
drolysis of sialic acid during fixation of the cells. When fresh intact sperm cell sus-
pension was used, only H6-3C4 and NUH2 showed a strong reactivity, in accordance
with the complement-dependent sperm immobilization in intact sperm cells shown
by these two antibodies. Only a very weak reactivity was found with antibodies 1132,
Dench, or C6 with fresh untreated sperm cells on immunofluorescence, and these
reactivities were enhanced greatly by sialidase treatment (data not shown).
Discussion
The specificity of mAb H6-3C4, which was established after fusion of lympho-
cytes of an infertile woman with mouse myeloma NS-1, may represent a part of the350 HUMAN SPERM CARBOHYDRATE ANTIGENS
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FIGURE 3 .
￿
Glycolipids of hu-
mansperm cells and their im-
munostaining patterns with
various antibodies . (Lane 1)
Monosialogangliosides from
humanOblood cells; (lane 2)
monosialogangliosides from
human placenta; (lanes 3, 6, 9,
12) total glycolipids from Folch's
lower-phase (nonpolar) fraction
of human sperm cells purified
by C18-silica gel column ; (lanes
4, 7, 10, 13) total glycolipids
from Folchs upper-phase (polar)
fraction of human sperm cells
purified by C18-silica gel column . (lane 5) upper neutral glycolipids from blood group O erythrocytes;
(lane 11) standard sialyl-I glycolipid (G10 ganglioside) . (A, lanes 1-4) Stained by 2% orcinol in 2M
sulfuric acid ; (B, lanes 5-7) stained by mAb 1B2, which defines terminal Galpl-4G1cNAc ; (C, lanes
8-10) stained bymAbH6-3C4; (D, lanes 11-13) stained bymAb NUH2,which defines sialyl-I . Bands
inA identified in theleft margin as a, b, c, 14 e,f, andgwere identified as ceramide monohexoside (CMH),
ceramide dihexoside (CDH), GM3, IV3NeuAcnLc4, IV3NeuAcn-Lc6, IV6NeuAcnLc6, and disialyl-I
(IV6NeuAc2-3GalP1-+ 4GlcNAcV13NeuAcnLc6), respectively . Bands immunostained by 1B2 in B,
marked in the left margin as a, b, c, d, and e, were identified as nLc4, nLc6, nLc8, iso-nLc8 (I antigen),
and nLclo, respectively. Slower migrating bands were not identified. Bandsimmunostained by H6-3C4
in C, marked in the leftmarftin as a, b, c, and d, were identified as IV3NeuAcnLc6, IV 6NeuAcn-Lc6,
VIII'NeuAcnLce, and VIIIINeuAcnLc8, respectively. (D) Only total upper-phase glycolipids from
sperm cells were immunostained, correspondingto sialyl-I . Slower migratingbands were not identified .
specificity detectable in antibodies present in infertile women, which causes
complement-dependent sperm immobilization. The specificity is now identified as
being directed to internally located, repetitive, unbranched N-acetyllactosamine struc-
ture, regardless of terminal substitutions at Gal, i.e ., sialyl-i, i, as well as fucosyl-i
structure . Anti-i antibodies, showingapreferential cold agglutination of fetal erythro-
cytes over adult erythrocytes, are oflow affinity and were found originally in sera
of patients with reticulosis, hemolytic anemia, or various hematopoietic malignan-
cies (30-32). The antibodyH6-3C4 also showedaweak butclear preferential hemag-
glutination ofneonatal erythrocytes at lowtemperature; this property again resembles
that of anti-i antibodies . However, i-antigen expressed on fetal erythrocytes and on
a few normal adulttissues is qualitativelydifferent in its fine specificityand binding
affinity from theMike antigenicity highly expressed at the sperm cell surface, defined
by H6-3C4 antibody (see below) .
TABLE III
Hemagglutination of Human Adult and Neonatal Erythrocytes by
H6-3C4 and Anti-i (Dench)
351
Hemagglutination Assay
Adult Neonatal
Antibody Temperature erythrocytes erythrocytes
H6-3C4 (1 mg/ml) 25°C - x 16
4°C x 1 x 128
Dench (serum) 25°C x10,000 x40,000
40C x40,000 x80,000352
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0.5
0.3
0.2
TABLE IV
Complement-dependent Sperm Immobilizing Test of Various mAbs
sup, culture supernatant of hybridoma containing 12 pg IgM/ml for H6-3C4;
18 pg IgM/ml for NUH2; 25 pg IgM/ml for C6; 8 pg IgM/ml for 1112; and
1 .9 pg IgM/ml for 1139.
t Serum ofmyeloma patients, Dench and Bostrum, containing anti-i myeloma
protein.
S No activity even at 100 times dilution.
The antigen i structure has been characterized as an unsubstituted, unbranched
N-acetyllactosamine, i.e., the structure included in nLc6, nLcs, but not terminally
sialylated derivatives (21, 22, 33; see reference 29 for review). In the longer type
2 chains, such as nLcs and nLcto, substitution at the terminal Gal may not strongly
affect the i reactivity (22), but substitution at the penultimate G1cNAc abolishes i
activity. In striking contrast, H6-3C4 reacts equally well with 2-3 or 2-"6sialylated
or nonsialylated ihaving two or three repeating N-acetyllactosaminyl structures. Fur-
thermore, it reacts with nLcs with fucosyl substitution at VII GlcNAc, which does
not react with anti-i. It is clear, therefore, that the reactivity of H6-3C4 is based
entirely on internally located, repetitive N-acetyllactosamine, while the majority of
anti-i specificity depends on an unsubstituted terminal structure. Another impor-
tant distinction between H6-3C4 and anti-i antibodies, and between the i-like an-
tigen in sperm and the i-antigen in various normal cells, is that H6-3C4 may be
capableof recognizing polylactosamine chain organizedin high densityat the sperm
cell surface, whichmayform ahigh-affinitybinding site whosereactivity is indepen-
C6 (I)
1 B9 (26SPG)
FIGURE 4. Reactivities of human
sperm cells with various mAbs anti-
NUH2(2,3 S-I)
￿
bodies directed to neolactoseries struc-
tures, before and after sialidase treat-
ment. Sperm cells were treated with
n
each
￿
and fixed on plastic surface
in
￿
ch well. Reactivities with each an-
tibody were tested before and after
182 (PG)
￿
treatment with Clostridium perfringens
sialidase as described in the text. Reac-
~ Streatment
￿
tivities are identified in each panel.
o-- No treatment
￿
Dench defines i (polylactosamine); 6C
defines I-antigen, i.e., lactoisooctaosyl-
ceramide; NUH2 reacts with 2-3
a z 1 0.5
￿
a z i 0.5
￿
sialyl-I; 1119 defines 2-+6 sialylpara
Sperm x 105/Well
￿
globoside; 1112 specifies terminal N-
acetyllactosamine as in nLc4, nLc6,
and nLcs.
Antibody Nontreated sperm Sialidase-treated sperm
H6-3C4 (sup)' x2,048 x4,056
NUH2 (sup) x 1,024 -
C6 (sup) -S x512
1112 (sup) - x2,048
1119 (sup) - -
Dench (serum)t - x4,056
Bostrum (serum)t - x4,056TSUJI ET AL .
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dent of temperature (at either 4°C or at 37°C) . Indeed, the reactivity of H6-3C4
with sperm cell antigen occurred at 37°C as well as 4°C (6-8) . In contrast, the majority
of the anti-i antibodies may not show a clear density-dependent recognition, and
the low density i antigen may form a low-affinity binding site whose reactivity is
restricted at 4°C . Since i-antigen at the fetal erythrocyte surface may be present
in low density, and its fine specificity is different from that present at the sperm cell
surface, the antibody H6-3C4 agglutinates fetal erythrocytes only weakly at 4°C .
Density-dependent recognition ofGM3 or Lex with a clear antigen threshold value
has been observed with some mAbs defining these structures (34, 35) . The antibody
M2590, showing a specific reaction with melanoma (10), is capable of recognizing
high-density but not low-density GM3 (34) . Cell type-specific antigenicity defined
by mAb is closely dependent on the unique organization of the antigen, rather than
the presence of a chemically unique antigen .
Expression of the i antigen, regardless of its density or organization, is relatively
limited in adult human tissue. The i antigen defined by mAb NCC1004 was found
to be associated with lung cancer and to be absent in the majority of normal adult
tissues, except in the mantle zone of lymph nodes, endothelium, and a few other
loci (36) . It is suspected that distribution of i or a2-í3 sialyl-i organized in high
density, which might be defined by the H6-3C4 antibody, must be highly limited
in normal tissue . Similarly, distribution ofa2-3 sialyl-I must alsobe limited, even
though I antigen is commonly expressed in a variety of tissues, particularly those
ofmesodermal origin . Native sperm cells may be unique in having a high density
ofa2-3 sialyl-i as well as a2-3 sialyl-I structure . Such a structural profile consti-
tutes a susceptible receptor to complement-dependent inactivation of sperm mo-
tility. The molecule defined by H6-3C4 and other antibodies may be found in both
glycosphingolipids and glycoproteins .
The specificity ofH6-3C4 may not represent the entire class ofantibodies present
in sera of infertile women that are capable ofinhibitingsperm motility . The surface
receptor ofnative sperm cells susceptible tocomplement-dependent immobilization
may consist of a series of sialylated or unsialylated type 2 chains, which are defined
by other antibodies with different specificities, such as NUH2 . Immobilization of
desialylated sperm can be caused by antibodies recognizing the Galß1-4G1cNAc
terminus, such as C6, 1B2, and Dench . Motility of native sperm cells was inhibited
by antibodies that recognize the internal repetitive N-acetyllactosamine, including
sialyl i and i (as typically shownby H6-3C4) ; and that recognize binary 2-3 sialyl
type 2 chain (sialyl I) (as demonstrated by NUH2) . In fact, examination ofhuman
sperm glycolipids revealed the presence of a series of lactosaminolipids, including
those representing i, sialyl i, and sialyl I structures. Nevertheless, the quantity of
glycolipids representing these structures in humansperm cells seems to be relatively
low, and the isolated glycolipidsmay not form high-affinity binding sites . The major
high-affinity receptor causing inactivation ofsperm motility must be a glycoprotein
characterized as having lactosaminoglycan, aswas previously found in fetal erythro-
cyte band III glycoprotein (37), placental fibronectin (38), and "embryoglycan" of
teratocarcinoma cells (39) . In fact, a high-affinity glycoprotein bearing lac-
tosaminoglycan was demonstrated in sperm cells (Kaizu, T, Y. Tsuji, S . Hakomori,
S. Isojima, unpublished data) . There must be other unidentified structures containing354
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polylactosamine that constitute a spectrum ofantibody specificities essentially respon-
sible for female infertility.
Hamilton et al. (40) established a hybridoma antibody EC1 after fusion of lym-
phocytes from multiparous mouse and mouse myeloma. Antibody EC1 reacts with
epididymal spermbut not testicular sperm. This property is identicalto that ofhuman
antibody H6-3C4. Interestingly, Hamilton et al. reported that ECl antigenwasex-
pressed not only at the sperm cell surface, but also at two-cell stage embryo. It disap-
peared at four-cell stage embryo andreappeared at the morula andblastocyst stage.
Since stage-specific expression of I and i antigens was previously found in preim-
plantation mouse embryo (41), a high-density expression of a2-3 sialyl-i and a2-3
sialyl-I in human sperm may also indicate the possibility that these could be stage-
specific antigens in early human embryogenesis. The antibody C6, which defines
binary N-acetyllactosamine structure, i.e., blood group I structure, was originally
obtained after immunization of syngeneic mice with sperm cells (13, 42). The ex-
pression ofC6-defined antigenwas closelyassociated with mesodermal development.
It is ofgreatinterest to correlatethese findings with a2-3 sialyl-i and a2-3 sialyl-I
expression in human sperm.
Summary
Theepitope structureofthe humansperm antigen reacting with antibodies present
in sera of infertile women has been studied using mAb H6-3C4, which produces
immobilization ofhuman sperm in the presence ofcomplement. Another antibody,
NUH2, which also induces human sperm immobilization, was used to substantiate
the presence of a receptor on sperm involved in susceptibility to immobilization.
Both antibodies definedtype 2chainpolylactosamine structure. H6-3C4 is directed
to internally located repetitive N-acetyllactosamine, i.e., sialyl-i, i, or fucosyl-i. NUH2
defines binary a2-3 sialyl type 2 chain, i.e., sialyl-I. Thus, the presence of anti-
bodies in the sera of infertile women directed to sperm lactosaminoglycan or lac-
tosaminolipid could be the basis for infertility in these cases.
Receivedfor publication 25 February 1988.
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